These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15112695)

  • 21. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
    Long L; Fox M; Sanne I; Rosen S
    AIDS; 2010 Mar; 24(6):915-9. PubMed ID: 20042849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
    Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of abacavir in 30 HIV-infected children from Durban, South Africa: report from a pilot study.
    Bobat R; Kindra G; Kiepiela P; Reddy S; Jeena PM; Adhikari M; Coovadia HM
    Pediatr Infect Dis J; 2010 Sep; 29(9):890. PubMed ID: 20720476
    [No Abstract]   [Full Text] [Related]  

  • 24. Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
    Johnson LF; May MT; Dorrington RE; Cornell M; Boulle A; Egger M; Davies MA
    PLoS Med; 2017 Dec; 14(12):e1002468. PubMed ID: 29232366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The social construction of ARVs in South Africa.
    Sember R
    Glob Public Health; 2008; 3 Suppl 2():58-75. PubMed ID: 19288353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
    Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
    AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do we need a national antiretroviral treatment register?
    Bekker LG; Wood R
    S Afr Med J; 2003 Jul; 93(7):514-5. PubMed ID: 12939922
    [No Abstract]   [Full Text] [Related]  

  • 29. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparing for highly active antiretroviral therapy rollout in rural South Africa: an assessment using the information, motivation, and behavioral skills model.
    Simon MD; Altice FL; Moll AP; Shange M; Friedland GH
    AIDS Care; 2010 Apr; 22(4):462-74. PubMed ID: 20204909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.
    Corbett EL; Marston B; Churchyard GJ; De Cock KM
    Lancet; 2006 Mar; 367(9514):926-37. PubMed ID: 16546541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Snapshot from Durban: new antiretroviral agents.
    Sterling TR
    Hopkins HIV Rep; 2000 Sep; 12(4):13. PubMed ID: 12184239
    [No Abstract]   [Full Text] [Related]  

  • 35. The inevitability of antiretrovirals.
    S Afr Med J; 2003 Aug; 93(8):572. PubMed ID: 14531106
    [No Abstract]   [Full Text] [Related]  

  • 36. Provision of antiretroviral therapy in South Africa: the nuts and bolts.
    Bekker LG; Venter F; Cohen K; Goemare E; Van Cutsem G; Boulle A; Wood R
    Antivir Ther; 2014; 19 Suppl 3():105-16. PubMed ID: 25310359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady growth in antiretroviral treatment provision by disease management and community treatment programmes.
    Johnson LF; McLeod HD
    S Afr Med J; 2007 May; 97(5):358-9. PubMed ID: 17599217
    [No Abstract]   [Full Text] [Related]  

  • 38. Paying the price for AIDS denialism.
    Bateman C
    S Afr Med J; 2007 Oct; 97(10):912-4. PubMed ID: 18000570
    [No Abstract]   [Full Text] [Related]  

  • 39. The imperative to treat: the South African state's constitutional obligations to provide antiretroviral medicines.
    Forman L
    Health Law Rev; 2003; 12(1):9-15. PubMed ID: 15742491
    [No Abstract]   [Full Text] [Related]  

  • 40. Depression, alcohol use, and stigma in younger versus older HIV-infected pregnant women initiating antiretroviral therapy in Cape Town, South Africa.
    Wong M; Myer L; Zerbe A; Phillips T; Petro G; Mellins CA; Remien RH; Shiau S; Brittain K; Abrams EJ
    Arch Womens Ment Health; 2017 Feb; 20(1):149-159. PubMed ID: 27815628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.